MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q2
hinzugefügt 09.08.2022
Epizyme P/B 2011-2025 | EPZM
P/B Jährlich Epizyme
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.355 | 5.98 | 5.79 | 3.14 | 4.51 | 2.76 | 2.14 | 3.94 | 4.98 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.98 | 0.355 | 3.73 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M |  USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.2 | $ 4.72 | 1.07 % | $ 783 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
0.979 | $ 3.3 | -1.93 % | $ 255 M | USA |
 |
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.37 | -2.05 % | $ 1.23 B | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
8.34 | $ 211.5 | 0.64 % | $ 5 B |  Danmark |
 |
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M |  Israel |
 |
Aptorum Group Limited
APM
|
0.347 | $ 1.3 | -2.26 % | $ 7.09 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.4 | -0.71 % | $ 8.18 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
AstraZeneca PLC
AZN
|
2.07 | $ 89.47 | -0.91 % | $ 96.9 B | Britain |
 |
Anika Therapeutics
ANIK
|
1.38 | $ 9.53 | 0.42 % | $ 140 M | USA |
 |
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | USA |
 |
BioVie
BIVI
|
0.128 | $ 1.46 | -3.09 % | $ 2.16 M | USA |
 |
Aytu BioScience
AYTU
|
0.127 | $ 2.32 | 1.93 % | $ 14.6 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | USA |
 |
Benitec Biopharma
BNTC
|
5.72 | $ 12.4 | -4.32 % | $ 510 M | USA |
 |
Baudax Bio
BXRX
|
-0.0321 | - | 0.59 % | $ 63 K | USA |
 |
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | USA |
 |
BioNTech SE
BNTX
|
5.29 | $ 94.63 | -1.43 % | $ 27.2 B |  Germany |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
9.34 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
17.1 | $ 569.74 | -1.94 % | $ 43.2 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 0.29 | -0.64 % | $ 631 M | Israel |
 |
Catalyst Biosciences
CBIO
|
0.428 | $ 14.33 | -6.43 % | $ 943 M | USA |
 |
Cerus Corporation
CERS
|
5.29 | $ 2.13 | -1.16 % | $ 393 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.122 | - | -16.75 % | $ 25.8 M | USA |
 |
Clovis Oncology
CLVS
|
-0.829 | - | -7.23 % | $ 13 M | USA |
 |
Biogen
BIIB
|
1.16 | $ 173.33 | 0.48 % | $ 25.2 B | USA |
 |
Cortexyme
CRTX
|
0.823 | - | -1.05 % | $ 67.1 M | USA |
 |
Celldex Therapeutics
CLDX
|
0.00176 | $ 27.64 | -1.07 % | $ 1.78 M | USA |
 |
Cellectar Biosciences
CLRB
|
-3.23 | $ 3.61 | -4.5 % | $ 44.1 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.42 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-12.6 | $ 11.42 | -0.17 % | $ 739 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
-0.577 | - | -5.68 % | $ 8.28 M | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Enochian Biosciences
ENOB
|
-5.41 | - | - | $ 40.5 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |